Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

<p>Trial schema</p>

Saved in:

书目详细资料
主要作者:	Stephanie L. Wethington (16354020) (author)
其他作者:	Payal D. Shah (14942077) (author), Lainie Martin (16354023) (author), Janos L. Tanyi (15047976) (author), Nawar Latif (16354026) (author), Mark Morgan (16354029) (author), Drew A. Torigian (15047964) (author), Diego Rodriguez (16354032) (author), Simon A. Smith (16354035) (author), Emma Dean (16354038) (author), Susan M. Domchek (14944434) (author), Ronny Drapkin (14937867) (author), Ie-Ming Shih (14964062) (author), Eric J. Brown (16354041) (author), Wei-Ting Hwang (15045089) (author), Deborah K. Armstrong (15134754) (author), Stephanie Gaillard (14947156) (author), Robert Giuntoli (16354044) (author), Fiona Simpkins (15048000) (author)
出版:	2025
主题:	Cancer Therapeutic Research and Development Clinical Research and Trials Clinical Trial Results Drug Resistance Gynecological Cancers Ovarian cancer
标签:	添加标签没有标签, 成为第一个标记此记录!

相似书籍